A Serious Threat Is Emerging To Apollo Endosurgery’s IGB Business
After divesting its surgical products, the company has two main businesses left, the ESS and IGB business. We are quite optimistic about their ESS business as the company has just […]
After divesting its surgical products, the company has two main businesses left, the ESS and IGB business. We are quite optimistic about their ESS business as the company has just […]
The company’s endo-bariatric products are flying off the shelves even if this comes at the cost of lower gross margins. Demand is set to continue at this brisk pace. The […]